Sections
1. Investment Snapshot
2. Price Chart
3. Valuation & Price Target
4. Business & Product Moat
5. Market & Macro
Discussion
Investment Snapshot
Price Chart
Valuation & Price Target
Business & Product Moat
Market & Macro
Discussion
Tourmaline Bio, Inc.
Investment Snapshot
Symbol
TALS
IPO Date (Actual)
2021-05-05
Offer Range
—
Shares Offered
8.8M
Total Shares Post-IPO
48.9M
Market Cap
—
Target Price
$00.00Implied Upside vs Midpoint
$00.00Use of Proceeds
—
Price Chart
Historic Price Chart - TALS
Valuation & Price Target
████████████████████
Business & Product Moat
████████████████████
Competitor Set
████████████████████Market & Macro
Sector context: Biological Products, (No Diagnostic Substances)
Same-industry IPOs from the last 365 days (as of 2026-06-04). Returns from IPO open price.
Median IPO open → current
-7.8%
win 50% · n=2Median first month
+1.5%
win 50% · n=2| Company | IPO Date | Open → Current | First Month |
|---|---|---|---|
JATT Zura Bio Ltd | 2026-04-17 | +4.8% | +4.8% |
AGMB Agomab Therapeutics NV | 2026-02-06 | -20.3% | -1.9% |